MedTrace Logo

Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting

NCT06142994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2024-10-30

No results posted yet for this study

Summary

The study aims to evaluate the effectiveness and safety of Atusin® CAP in reducing the severity of acute bronchitis.

Conditions

  • Acute Bronchitis

Interventions

DIETARY_SUPPLEMENT

Atusin CAP

This food supplement contains a distillate of 4 types of purified oils - eucalyptus, sweet orange, lemon and myrtle, rich in 1,8-cineol, limonene, alpha-pinene in the ratio: 66:32:1:1, bromelain and green Brazilian propolis in a gastro-resistant capsule. The product contains excipients: microcrystalline cellulose, silica dioxide, copovidone, magnesium stearate.

DIETARY_SUPPLEMENT

Placebo

The placebo product will be identical in shape, appearance and color to the active product and will have the same composition but without the active ingredients.

Sponsors & Collaborators

  • Neopharm Bulgaria Ltd.

    lead INDUSTRY

Principal Investigators

  • Vladimir Hodzhev, Prof, PhD · Head of Pulmonology clinic in the UMHAT "Sveti Georgi", Medical University-Plovdiv

  • Diana Petkova, Prof, PhD · Clnic of Pneumology at UMHAT "St. Marina", Medical University - Varna

  • Rossen Petkov, Prof, PhD · Head of Pulmonology clinic in the UMHAT St Ivan Rilski, Medical University of Sofia

  • Yavor Ivanov, Prof, PhD · Head of Pneumology and Phthisiology clinic in the UMHAT "Dr. Georgi Stranski"

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2024-06-20
Completion
2024-06-20

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06142994 on ClinicalTrials.gov